Notícias e Atividades da Foresight Diagnostics

A Foresight Diagnostics pertence à Quest Diagnostics.

Quest Diagnostics é uma das ...

• Forbes Global 2000 (#1096);
• Fortune 500 (#423);
• Russell 3000;
• S&P 500;
• TOB Iconic 10,000.

Quest Diagnostics é uma empresa listada sob o símbolo DGX (US).

Quest Diagnostics tem presença direta em 4 países.

Quest Diagnostics possui 6 subsidiárias incluindo Centogene, Foresight Diagnostics e Haystack Oncology.

Eles estão dentro:

• Biotecnologia57%
• Saúde43%

Fusão, aquisição e financiamento envolvendo Quest Diagnostics.

• Natera has announced the acquisition of Foresight Diagnostics  (publicado em 5 de dezembro de 2025).

Veja o organograma con seus 13 executivos principais

Biografias mais buscadas da Foresight Diagnostics

• Jake Chabon, Chief Executive Officer and Chief Scientific Officer
• Maximilian Diehn, Board Member
• Sandra Close, Chief Operating Officer and Chief Compliance Officer

Recentes movimentos de executivos em Foresight Diagnostics

• Mckenzie Carlisle antes Senior Director, Regulatory Operations & Compliance, agora é Senior Director, Regulatory Affairs & Quality Assurance  (Notícia publicada em 10 de março de 2026).

Recentes movimentos de executivos em Quest Diagnostics

• Timothy Wentworth, ingressou na Companhia como Director  (Notícia publicada em 13 de março de 2026).
• Benjamin Beauvalot, ingressou na Companhia como Senior Vice President, Chief Strategy and Mergers and Acquisitions Officer  (Notícia publicada em 26 de fevereiro de 2026).

Criar um alerta
para seguir os movimentos de executivos da Foresight Diagnostics.

Quest Diagnostics possui 2.405 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e BioNTech (Alemanha).

Popular M&A news in Biotecnologia

• IMU Biosciences acaba de anunciar uma arrecadação de fundos de 53 milhões de dólares. (publicado em 3 de junho de 2026).
• NewLimit acaba de anunciar uma arrecadação de fundos de 435 milhões de dólares. (publicado em 3 de junho de 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (publicado em 1 de junho de 2026)..

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Valerie Hanote - Non-Executive Director da Eurofins

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Foresight Diagnostics

• Natera Acquires Foresight Diagnostics | foresight-dx.com
• Foresight Diagnostics Announces Multiple Presentations in Lymphoma Featuring PhasED-Seq™ Ultrasensitive MRD Analysis at the upcoming ASH Annual Meeting | foresight-dx.com
• Foresight Diagnostics to Present Clinical Performance Data on Foresight CLARITY™ MRD at IASLC 2025 World Conference on Lung Cancer | foresight-dx.com
• Foresight Diagnostics and Roche Enter Licensing Agreement for PhasED-Seq™ Technology in Non-Hodgkin's Lymphoma | foresight-dx.com
• Foresight Diagnostics Announces Publication of Landmark Study Demonstrating Prognostic Value of Ultrasensitive ctDNA-MRD Detection in Large B-Cell Lymphoma | foresight-dx.com
• Foresight Diagnostics and Partners to Present Independent Validation Data for its CLARITY™ MRD Assay at the 2025 European Hematology Association (EHA) Congress and International Conference on Malignant Lymphoma (ICML) | foresight-dx.com
• Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma | foresight-dx.com
• Foresight Diagnostics Presents Independent Validation of its CLARITY Minimal Residual Disease Assay in Multi-center Study of Frontline DLBCL at the 2025 ASCO Annual Meeting | foresight-dx.com
• Foresight Diagnostics to Participate in the Jefferies Global Healthcare Conference | foresight-dx.com
• Foresight Diagnostics and Partners to Present New Data on Ultra-sensitive Minimal Residual Disease Detection and Clinical Trial Progress at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting | foresight-dx.com
• View more press releases Close

Redes sociais sobre Foresight Diagnostics

• Foresight Diagnostics na Wikipedia, Google News e Yahoo Finance
• Foresight Diagnostics na LinkedIn, X (Twitter) e YouTube